Three key studies addressing the future of HIV care for people living with HIV (PLWH) presented at the 26th International ...

If you're a Black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been ...

Disruptions to funding and new policies aimed at aligning foreign aid programs with the Trump administration’s agenda have ...

A study reveals economic inequality is a key predictor of pandemic response effectiveness, urging nations to prioritize ...

A South African clinical trial has found a new HIV treatment regimen causes significantly less weight gain than the standard dolutegravir treatment.

Among healthcare providers, 89% (n=16/18) reported a positive overall opinion of administering CAB LA for PrEP in their practice. Prescribers cited benefits of regular injection visits, including ...

An experimental combination pill containing islatravir and ulonivirine shows promise as a weekly oral treatment option, ...

ViiV Healthcare’s Dovato has been approved for use in the US and EU since 2019, but its sales remain overshadowed by Gilead’s Biktarvy.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced data to be presented this week at the 26 th International AIDS Conference ...

South Africa accounts for over half of all lenacapavir (LEN) users in Africa, with health department data revealing 31,297 of ...

ACTG, a global clinical trials network focused on HIV and other infectious diseases, announced today that it will make three ...

Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage ...